1. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
- Author
-
Fazeli, PL, Casaletto, KB, Paolillo, E, Moore, RC, Moore, DJ, and The Hnrp Group
- Subjects
Humans ,HIV Infections ,AIDS Dementia Complex ,Activities of Daily Living ,Sensitivity and Specificity ,Neuropsychological Tests ,Psychometrics ,Aged ,Aged ,80 and over ,Middle Aged ,Female ,Male ,Executive Function ,Self Report ,Cognitive Dysfunction ,Cognitive assessment ,External validity. ,HIV/AIDS ,IADLs ,MoCA ,HIV ,AIDS ,External validity ,Neurosciences ,Brain Disorders ,Clinical Research ,Neurodegenerative ,Prevention ,Dementia ,Behavioral and Social Science ,Aging ,Mental Health ,Acquired Cognitive Impairment ,Mental health ,Experimental Psychology ,Psychology ,Cognitive Sciences - Abstract
As the HIV+ population ages, the risk for and need to screen for HIV-associated neurocognitive disorders (HAND) increases. The aim of this study is to determine the utility and ecological validity of the Montreal Cognitive Assessment (MoCA) among older HIV+ adults. A total of 100 HIV+ older adults aged 50 years or over completed a comprehensive neuromedical and neurocognitive battery, including the MoCA and several everyday functioning measures. The receiver operating characteristic curve indicates ≤26 as the optimal cut-off balancing sensitivity (84.2%) and specificity (55.8%) compared to "gold standard" impairment as measured on a comprehensive neuropsychological battery. Higher MoCA total scores are significantly (p < .01) associated with better performance in all individual cognitive domains except motor abilities, with the strongest association with executive functions (r = -0.49, p
- Published
- 2017